Mostra i principali dati dell'item

Assess the reporting quality of randomized-controlled trials in patients with relapsed and/or refractory multiple myeloma based on the consort statement

dc.contributor.advisorΜπάκαλος, Γεώργιοςel
dc.creatorΑργυρίου, Ειρήνηel
dc.date.accessioned2018-11-22T10:03:18Z
dc.date.available2018-11-22T10:03:18Z
dc.date.issued2017
dc.identifier.other16863
dc.identifier.urihttp://hdl.handle.net/11615/49630
dc.identifier.urihttp://dx.doi.org/10.26253/heal.uth.3936
dc.language.isoelen
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subject.otherΠολλαπλό μυέλωμαel
dc.subject.otherΙατρική στατιστικήel
dc.titleΑξιολόγηση της ποιότητας των τυχαιοποιημένων-ελεγχόμενων μελετών σε ασθενείς με υποτροπιάζων και/η ανθεκτικό πολλαπλό μυέλωμα με βάση τη δήλωση consortel
dc.titleAssess the reporting quality of randomized-controlled trials in patients with relapsed and/or refractory multiple myeloma based on the consort statementen
dc.typemasterThesisen
heal.recordProviderΠανεπιστήμιο Θεσσαλίας - Βιβλιοθήκη και Κέντρο Πληροφόρησηςel
heal.academicPublisherΠανεπιστήμιο Θεσσαλίας. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής.el
heal.academicPublisherIDuthen
heal.fullTextAvailabilitytrueen
dc.rights.accessRightsfreeen


Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International